{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:06:26Z","timestamp":1793387186716,"version":"4.5.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00203-023-03602-z","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T02:01:26Z","timestamp":1689040886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The possible role of Helicobacter pylori in liver diseases"],"prefix":"10.1007","volume":"205","author":[{"given":"Mahnaz","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeleh","family":"Attar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mohammadbeigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Peymani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Bolori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Fardsanei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,11]]},"reference":[{"key":"3602_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4103\/2221-1691.338919","volume":"12","author":"RF Abdel-Rahman","year":"2022","unstructured":"Abdel-Rahman RF (2022) Non-alcoholic fatty liver disease: epidemiology, pathophysiology and an update on the therapeutic approaches. Asian Pac J Trop Biomed 12:99","journal-title":"Asian Pac J Trop Biomed"},{"key":"3602_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fmed.2020.00096","volume":"7","author":"A Abdel-Razik","year":"2020","unstructured":"Abdel-Razik A et al (2020) Helicobacter pylori as an initiating factor of complications in patients with cirrhosis: a single-center observational study. Front Med 7:96","journal-title":"Front Med"},{"key":"3602_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2147\/DMSO.S237866","volume":"13","author":"YE-E Abo-Amer","year":"2020","unstructured":"Abo-Amer YE-E et al (2020) Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease (Nafld) in a developing country: a cross-sectional study. Diabetes Metab Syndr Obes Targets Ther 13:619","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"3602_CR4","volume-title":"Helicobacter pylori: molecular and cellular biology","author":"M Achtman","year":"2001","unstructured":"Achtman M, Suerbaum S (2001) Helicobacter pylori: molecular and cellular biology. Horizon Scientific Press, Wymondham"},{"key":"3602_CR5","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1017\/S0950268818000857","volume":"146","author":"F Alarid-Escudero","year":"2018","unstructured":"Alarid-Escudero F et al (2018) Force of infection of helicobacter pylori in Mexico: evidence from a national survey using a hierarchical Bayesian model. Epidemiol Infect 146:961\u2013969","journal-title":"Epidemiol Infect"},{"key":"3602_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fonc.2019.00075","volume":"9","author":"KO Alfarouk","year":"2019","unstructured":"Alfarouk KO et al (2019) The possible role of Helicobacter pylori in gastric cancer and its management. Front Oncol 9:75","journal-title":"Front Oncol"},{"key":"3602_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12756","volume":"25","author":"CS Alvarez","year":"2020","unstructured":"Alvarez CS et al (2020) Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala. Helicobacter 25:e12756","journal-title":"Helicobacter"},{"key":"3602_CR8","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3390\/nu10060764","volume":"10","author":"CJ Andersen","year":"2018","unstructured":"Andersen CJ (2018) Impact of dietary cholesterol on the pathophysiology of infectious and autoimmune disease. Nutrients 10:764","journal-title":"Nutrients"},{"key":"3602_CR9","doi-asserted-by":"publisher","first-page":"7430","DOI":"10.3390\/ijms21197430","volume":"21","author":"S Ansari","year":"2020","unstructured":"Ansari S, Yamaoka Y (2020) Helicobacter pylori virulence factor cytotoxin-associated Gene A (CagA)-mediated gastric pathogenicity. Int J Mol Sci 21:7430","journal-title":"Int J Mol Sci"},{"key":"3602_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43141-021-00293-1","volume":"20","author":"AM Attallah","year":"2022","unstructured":"Attallah AM, Albannan MS, Ghaly MF, Sallam SE, Amer MM, Attia AA (2022) Prevalence of Helicobacter pylori infection in patients with chronic hepatitis C. J Genet Eng Biotechnol 20:1\u20137","journal-title":"J Genet Eng Biotechnol"},{"key":"3602_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejrad.2018.01.025","volume":"101","author":"C Ayuso","year":"2018","unstructured":"Ayuso C et al (2018) Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Eur J Radiol 101:72\u201381","journal-title":"Eur J Radiol"},{"key":"3602_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-017-0517-9","volume":"10","author":"B Badgwell","year":"2017","unstructured":"Badgwell B, Das P, Ajani J (2017) Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy. J Hematol Oncol 10:1\u20137","journal-title":"J Hematol Oncol"},{"key":"3602_CR13","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.3748\/wjg.v22.i8.2592","volume":"22","author":"MK Baeg","year":"2016","unstructured":"Baeg MK, Yoon SK, Ko S-H, Noh Y-S, Lee I-S, Choi M-G (2016) Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease. World J Gastroenterol 22:2592","journal-title":"World J Gastroenterol"},{"key":"3602_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/cells10010027","volume":"10","author":"J Baj","year":"2020","unstructured":"Baj J et al (2020) Helicobacter pylori virulence factors\u2014mechanisms of bacterial pathogenicity in the gastric microenvironment. Cells 10:27","journal-title":"Cells"},{"key":"3602_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","volume":"13","author":"JM Banales","year":"2016","unstructured":"Banales JM et al (2016) Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol 13:261\u2013280","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3602_CR16","first-page":"594","volume":"1861","author":"A Bashiri","year":"2016","unstructured":"Bashiri A et al (2016) Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis. Biochim Biophys Acta (BBA) Mol Cell Biol Lipids 1861:594\u2013605","journal-title":"Biochim Biophys Acta (BBA) Mol Cell Biol Lipids"},{"key":"3602_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Investig 115:209\u2013218","journal-title":"J Clin Investig"},{"key":"3602_CR18","doi-asserted-by":"publisher","first-page":"394","DOI":"10.4254\/wjh.v6.i6.394","volume":"6","author":"F Bessone","year":"2014","unstructured":"Bessone F, Poles N, Roma MG (2014) Challenge of liver disease in systemic lupus erythematosus: clues for diagnosis and hints for pathogenesis. World J Hepatol 6:394","journal-title":"World J Hepatol"},{"key":"3602_CR19","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/sj.embor.7400812","volume":"7","author":"MJ Blaser","year":"2006","unstructured":"Blaser MJ (2006) Who are we? Indigenous microbes and the ecology of human diseases. EMBO Rep 7:956\u2013960","journal-title":"EMBO Rep"},{"key":"3602_CR20","volume-title":"Cancer incidence in five continents","author":"F Bray","year":"2017","unstructured":"Bray F et al (2017) Cancer incidence in five continents, vol 11. International Agency for Research on Cancer, Lyon"},{"key":"3602_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-020-00234-1","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ et al (2021) Cholangiocarcinoma. Nat Rev Dis Prim 7:1\u201317","journal-title":"Nat Rev Dis Prim"},{"key":"3602_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/hep.29115","volume":"66","author":"DJ Bruden","year":"2017","unstructured":"Bruden DJ et al (2017) Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort. Hepatology 66:37\u201345","journal-title":"Hepatology"},{"key":"3602_CR23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jhep.2016.04.030","volume":"65","author":"N Bulteel","year":"2016","unstructured":"Bulteel N et al (2016) Factors associated with spontaneous clearance of chronic hepatitis C virus infection. J Hepatol 65:266\u2013272","journal-title":"J Hepatol"},{"key":"3602_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1242\/dmm.027649","volume":"10","author":"MD Burkitt","year":"2017","unstructured":"Burkitt MD, Duckworth CA, Williams JM, Pritchard DM (2017) Helicobacter pylori-induced gastric pathology: insights from in vivo and ex vivo models. Dis Models Mech 10:89\u2013104","journal-title":"Dis Models Mech"},{"key":"3602_CR25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1474-9726.2009.00517.x","volume":"8","author":"ME Carlson","year":"2009","unstructured":"Carlson ME et al (2009) Relative roles of TGF-\u03b21 and Wnt in the systemic regulation and aging of satellite cell responses. Aging Cell 8:676\u2013689","journal-title":"Aging Cell"},{"key":"3602_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1096\/fj.04-2291fje","volume":"19","author":"M Carmiel-Haggai","year":"2005","unstructured":"Carmiel-Haggai M, Cederbaum AI, Nieto N (2005) A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J 19:136\u2013138","journal-title":"FASEB J"},{"key":"3602_CR27","first-page":"88","volume":"30","author":"GP Caviglia","year":"2018","unstructured":"Caviglia GP, Olivero A, Rosso C, Bosco C, Ribaldone DG, Fagoonee S (2018) Laboratory evidence of Helicobacter species infection in hepatocellular carcinoma. Min Biotecnol 30:88\u201393","journal-title":"Min Biotecnol"},{"key":"3602_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N et al (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67:328\u2013357","journal-title":"Hepatology"},{"key":"3602_CR29","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/MEG.0000000000001601","volume":"32","author":"C Chen","year":"2020","unstructured":"Chen C et al (2020) Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome. Eur J Gastroenterol Hepatol 32:857","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3602_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acr.2020.10.001","volume":"149","author":"S Chidambaranathan-Reghupaty","year":"2021","unstructured":"Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D (2021) Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv Cancer Res 149:1\u201361","journal-title":"Adv Cancer Res"},{"key":"3602_CR31","first-page":"394","volume":"8","author":"M Cojocaru","year":"2013","unstructured":"Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD (2013) Liver involvement in patients with systemic autoimmune diseases. Maedica 8:394","journal-title":"Maedica"},{"key":"3602_CR32","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0016-5085(14)63307-2","volume":"5","author":"ACD Cruz","year":"2014","unstructured":"Cruz ACD et al (2014) 379 Characteristics and long-term prognosis of lean patients with nonalcoholic fatty liver disease. Gastroenterology 5:909","journal-title":"Gastroenterology"},{"key":"3602_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12817","volume":"26","author":"R Dangtakot","year":"2021","unstructured":"Dangtakot R et al (2021) CagA+ Helicobacter pylori infection and N-nitrosodimethylamine administration induce cholangiocarcinoma development in hamsters. Helicobacter 26:e12817","journal-title":"Helicobacter"},{"key":"3602_CR34","first-page":"109","volume":"62","author":"R deOgburn","year":"2012","unstructured":"deOgburn R, Leite JO, Ratliff J, Volek JS, McGrane MM, Fernandez ML (2012) Effects of increased dietary cholesterol with carbohydrate restriction on hepatic lipid metabolism in Guinea pigs. Comp Med 62:109\u2013115","journal-title":"Comp Med"},{"key":"3602_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4254\/wjh.v11.i1.1","volume":"11","author":"A Desai","year":"2019","unstructured":"Desai A, Sandhu S, Lai J-P, Sandhu DS (2019) Hepatocellular carcinoma in non-cirrhotic liver: a comprehensive review. World J Hepatol 11:1","journal-title":"World J Hepatol"},{"key":"3602_CR36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.aej.2020.01.034","volume":"59","author":"A Din","year":"2020","unstructured":"Din A, Li Y, Liu Q (2020) Viral dynamics and control of hepatitis B virus (HBV) using an epidemic model. Alex Eng J 59:667\u2013679","journal-title":"Alex Eng J"},{"key":"3602_CR37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S0016-5085(03)00666-8","volume":"125","author":"S Dooley","year":"2003","unstructured":"Dooley S et al (2003) Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 125:178\u2013191","journal-title":"Gastroenterology"},{"key":"3602_CR38","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3390\/jcm9040933","volume":"9","author":"M Doulberis","year":"2020","unstructured":"Doulberis M et al (2020) Active Helicobacter pylori infection is independently associated with nonalcoholic steatohepatitis in morbidly obese patients. J Clin Med 9:933","journal-title":"J Clin Med"},{"key":"3602_CR39","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1023\/A:1013782408510","volume":"47","author":"M Durazzo","year":"2002","unstructured":"Durazzo M et al (2002) Helicobacter pylori seroprevalence in patients with autoimmune hepatitis. Dig Dis Sci 47:380\u2013383","journal-title":"Dig Dis Sci"},{"key":"3602_CR40","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.3748\/wjg.v10.i21.3179","volume":"10","author":"M Durazzo","year":"2004","unstructured":"Durazzo M et al (2004) Lack of association between seroprevalence of Helicobacter pylori infection and primary biliary cirrhosis. World J Gastroenterol WJG 10:3179","journal-title":"World J Gastroenterol WJG"},{"key":"3602_CR41","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1084\/jem.20041035","volume":"200","author":"B Eksteen","year":"2004","unstructured":"Eksteen B et al (2004) Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med 200:1511\u20131517","journal-title":"J Exp Med"},{"key":"3602_CR42","doi-asserted-by":"publisher","first-page":"7610","DOI":"10.1073\/pnas.112203099","volume":"99","author":"JW Fahey","year":"2002","unstructured":"Fahey JW et al (2002) Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo [a] pyrene-induced stomach tumors. Peoc Natl Acad Sci USA 99:7610\u20137615","journal-title":"Peoc Natl Acad Sci USA"},{"key":"3602_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fmicb.2018.00073","volume":"9","author":"N Fan","year":"2018","unstructured":"Fan N, Peng L, Xia Z, Zhang L, Wang Y, Peng Y (2018) Helicobacter pylori infection is not associated with non-alcoholic fatty liver disease: a cross-sectional study in China. Front Microbiol 9:73","journal-title":"Front Microbiol"},{"key":"3602_CR44","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1523-5378.1996.tb00037.x","volume":"1","author":"N Figura","year":"1996","unstructured":"Figura N (1996) Hypothesis: Helicobacter toxins and liver. Helicobacter 1:187\u2013189","journal-title":"Helicobacter"},{"key":"3602_CR45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.25122\/jml-2018-0035","volume":"11","author":"PV Filip","year":"2018","unstructured":"Filip PV, Cuciureanu D, Diaconu LS, Vladareanu AM, Pop CS (2018) MALT lymphoma: epidemiology, clinical diagnosis and treatment. J Med Life 11:187","journal-title":"J Med Life"},{"key":"3602_CR46","first-page":"429","volume":"115","author":"W Fischbach","year":"2018","unstructured":"Fischbach W, Malfertheiner P (2018) Helicobacter pylori infection: when to eradicate, how to diagnose and treat. Deutsches \u00c4rzteblatt Int 115:429","journal-title":"Deutsches \u00c4rzteblatt Int"},{"key":"3602_CR47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1128\/jcm.33.2.445-454.1995","volume":"33","author":"J Fox","year":"1995","unstructured":"Fox J et al (1995) Helicobacter bilis sp. nov., a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice. J Clin Microbiol 33:445\u2013454","journal-title":"J Clin Microbiol"},{"key":"3602_CR48","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3390\/cells9051212","volume":"9","author":"E Geervliet","year":"2020","unstructured":"Geervliet E, Bansal R (2020) Matrix metalloproteinases as potential biomarkers and therapeutic targets in liver diseases. Cells 9:1212","journal-title":"Cells"},{"key":"3602_CR49","first-page":"83","volume":"5","author":"AA Ghweil","year":"2022","unstructured":"Ghweil AA, Okasha A, Mahmoud MAE, Bazeed SES (2022) Relation between Helicobacter pylori infection and non-alcoholic fatty liver disease. SVU Int J Med Sci 5:83\u201389","journal-title":"SVU Int J Med Sci"},{"key":"3602_CR50","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/hel.12340","volume":"21","author":"E Goni","year":"2016","unstructured":"Goni E, Franceschi FJH (2016) Helicobacter pylori and extragastric diseases. Helicobacter 21:45\u201348","journal-title":"Helicobacter"},{"key":"3602_CR51","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/labinvest.2009.90","volume":"89","author":"M-J Goo","year":"2009","unstructured":"Goo M-J et al (2009) Helicobacter pylori promotes hepatic fibrosis in the animal model. Lab Investig 89:1291\u20131303","journal-title":"Lab Investig"},{"key":"3602_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-022-04811-y","volume":"13","author":"R Guo","year":"2022","unstructured":"Guo R et al (2022) CircMAN1A2 is upregulated by Helicobacter pylori and promotes development of gastric cancer. Cell Death Dis 13:1\u201311","journal-title":"Cell Death Dis"},{"key":"3602_CR53","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","volume":"67","author":"H Hagstr\u00f6m","year":"2017","unstructured":"Hagstr\u00f6m H et al (2017) Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. J Hepatol 67:1265\u20131273","journal-title":"J Hepatol"},{"key":"3602_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260994","volume":"16","author":"YM Han","year":"2021","unstructured":"Han YM et al (2021) The association between Helicobacter pylori with nonalcoholic fatty liver disease assessed by controlled attenuation parameter and other metabolic factors. PLoS ONE 16:e0260994","journal-title":"PLoS ONE"},{"key":"3602_CR55","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5152\/tjg.2022.21467","volume":"33","author":"K Heydari","year":"2022","unstructured":"Heydari K et al (2022) Helicobacter pylori infection and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Turk J Gastroenterol 33:171\u2013181","journal-title":"Turk J Gastroenterol"},{"key":"3602_CR56","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/v12020126","volume":"12","author":"JK-T Ho","year":"2020","unstructured":"Ho JK-T, Jeevan-Raj B, Netter H-J (2020) Hepatitis B virus (HBV) subviral particles as protective vaccines and vaccine platforms. Viruses 12:126","journal-title":"Viruses"},{"key":"3602_CR57","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(03)14547-3","volume":"362","author":"M H\u00f6cker","year":"2003","unstructured":"H\u00f6cker M, Hohenberger P (2003) Helicobacter pylori virulence factors\u2014one part of a big picture. Lancet 362:1231\u20131233","journal-title":"Lancet"},{"key":"3602_CR58","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/gutjnl-2014-308163","volume":"64","author":"Y-C Hsu","year":"2015","unstructured":"Hsu Y-C et al (2015) Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection. Gut 64:495\u2013503","journal-title":"Gut"},{"key":"3602_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-230X-12-123","volume":"12","author":"X Hu","year":"2012","unstructured":"Hu X et al (2012) Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units. BMC Gastroenterol 12:1\u20139","journal-title":"BMC Gastroenterol"},{"key":"3602_CR60","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","volume":"22","author":"M Iannacone","year":"2021","unstructured":"Iannacone M, Guidotti LG (2021) Immunobiology and pathogenesis of hepatitis B virus infection. Nat Rev Immunol 22:19\u201332","journal-title":"Nat Rev Immunol"},{"key":"3602_CR61","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/antibiotics9060293","volume":"9","author":"E Ierardi","year":"2020","unstructured":"Ierardi E et al (2020) The puzzle of coccoid forms of Helicobacter pylori: beyond basic science. Antibiotics 9:293","journal-title":"Antibiotics"},{"key":"3602_CR62","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/cancers14020446","volume":"14","author":"E Ishikawa","year":"2022","unstructured":"Ishikawa E, Nakamura M, Satou A, Shimada K, Nakamura S (2022) Mucosa-associated lymphoid tissue (MALT) lymphoma in the gastrointestinal tract in the modern era. Cancers 14:446","journal-title":"Cancers"},{"key":"3602_CR63","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3347\/kjp.2021.59.4.363","volume":"59","author":"I Jala","year":"2021","unstructured":"Jala I et al (2021) Helicobacter pylori GroEL seropositivity is associated with an increased risk of opisthorchis viverrini-associated hepatobiliary abnormalities and cholangiocarcinoma. Korean J Parasitol 59:363","journal-title":"Korean J Parasitol"},{"key":"3602_CR64","doi-asserted-by":"publisher","first-page":"2150101","DOI":"10.1142\/S1793524521501011","volume":"15","author":"MN Jan","year":"2022","unstructured":"Jan MN, Zaman G, Ali N, Ahmad I, Shah Z (2022) Optimal control application to the epidemiology of HBV and HCV co-infection. Int J Biomath 15:2150101","journal-title":"Int J Biomath"},{"key":"3602_CR65","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1269\/jrr.0629","volume":"48","author":"W-I Jeong","year":"2007","unstructured":"Jeong W-I et al (2007) Acute effects of fast neutron irradiation on mouse liver. J Radiat Res 48:233\u2013240","journal-title":"J Radiat Res"},{"key":"3602_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41043-021-00280-9","volume":"41","author":"M Keikha","year":"2022","unstructured":"Keikha M, Sahebkar A, Yamaoka Y, Karbalaei M (2022) Helicobacter pylori cagA status and gastric mucosa-associated lymphoid tissue lymphoma: a systematic review and meta-analysis. J Health Popul Nutr 41:1\u201311","journal-title":"J Health Popul Nutr"},{"key":"3602_CR67","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/labinvest.2010.109","volume":"90","author":"M-R Ki","year":"2010","unstructured":"Ki M-R et al (2010) Helicobacter pylori accelerates hepatic fibrosis by sensitizing transforming growth factor-\u03b21-induced inflammatory signaling. Lab Investig 90:1507\u20131516","journal-title":"Lab Investig"},{"key":"3602_CR68","doi-asserted-by":"publisher","first-page":"131","DOI":"10.7704\/kjhugr.2021.0060","volume":"22","author":"JW Kim","year":"2022","unstructured":"Kim JW et al (2022) Impact of Helicobacter pylori eradication on the risk of incident nonalcoholic fatty liver disease: a cohort study. Korean J Helicobacter Upper Gastrointest Res 22:131\u2013138","journal-title":"Korean J Helicobacter Upper Gastrointest Res"},{"key":"3602_CR69","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3390\/pathogens9121062","volume":"9","author":"P Krzy\u017cek","year":"2020","unstructured":"Krzy\u017cek P, Grande R, Migda\u0142 P, Paluch E, Go\u015bciniak G (2020) Biofilm formation as a complex result of virulence and adaptive responses of Helicobacter pylori. Pathogens 9:1062","journal-title":"Pathogens"},{"key":"3602_CR70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4251\/wjgo.v14.i1.55","volume":"14","author":"Y-C Kuo","year":"2022","unstructured":"Kuo Y-C et al (2022) Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: from the oral cavity to rectum. World J Gastrointest Oncol 14:55","journal-title":"World J Gastrointest Oncol"},{"key":"3602_CR71","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3390\/microorganisms8101470","volume":"8","author":"KC Lau","year":"2020","unstructured":"Lau KC, Burak KW, Coffin CS (2020) Impact of hepatitis B virus genetic variation, integration, and lymphotropism in antiviral treatment and oncogenesis. Microorganisms 8:1470","journal-title":"Microorganisms"},{"key":"3602_CR72","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/ijms22010199","volume":"22","author":"NY Lee","year":"2020","unstructured":"Lee NY, Suk KT (2020) The role of the gut microbiome in liver cirrhosis treatment. Int J Mol Sci 22:199","journal-title":"Int J Mol Sci"},{"key":"3602_CR73","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1146\/annurev-med-042220-020814","volume":"73","author":"Y-C Lee","year":"2022","unstructured":"Lee Y-C, Dore MP, Graham DY (2022) Diagnosis and treatment of Helicobacter pylori infection. Ann Rev Med 73:183\u2013195","journal-title":"Ann Rev Med"},{"key":"3602_CR74","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12635","volume":"24","author":"M Leja","year":"2019","unstructured":"Leja M, Grinberga-Derica I, Bilgilier C, Steininger C (2019) Epidemiology of Helicobacter pylori infection. Helicobacter 24:e12635","journal-title":"Helicobacter"},{"key":"3602_CR75","unstructured":"Li T (2021) The differences of prokaryotic pan-genome analysis on complete genomes and simulated metagenome-assembled genomes"},{"key":"3602_CR76","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/apt.14391","volume":"47","author":"D Li","year":"2018","unstructured":"Li D, Yan P, Abou-Samra AB, Chung R, Butt A (2018) Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES. Aliment Pharmacol Ther 47:246\u2013258","journal-title":"Aliment Pharmacol Ther"},{"key":"3602_CR77","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/07388551.2021.1947962","volume":"42","author":"M Li","year":"2021","unstructured":"Li M, Qin J, Xiong K, Jiang B, Zhang T (2021) Review of arginase as a promising biocatalyst: characteristics, preparation, applications and future challenges. Crit Rev Biotechnol 42:651\u2013667","journal-title":"Crit Rev Biotechnol"},{"key":"3602_CR78","doi-asserted-by":"crossref","unstructured":"Li GZ, Doherty GM, Wang J (2022) Surgical management of gastric cancer: a review. JAMA Surg","DOI":"10.1001\/jamasurg.2022.0182"},{"key":"3602_CR79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.7150\/ijms.3.57","volume":"3","author":"Z Liu","year":"2006","unstructured":"Liu Z, Hou J (2006) Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection. Int J Med Sci 3:57","journal-title":"Int J Med Sci"},{"key":"3602_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1018322","author":"Y Liu","year":"2022","unstructured":"Liu Y, Xu H, Zhao Z, Dong Y, Wang X, Niu J (2022) No evidence for a causal link between Helicobacter pylori infection and nonalcoholic fatty liver disease: a bidirectional Mendelian randomization study. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2022.1018322","journal-title":"Front Microbiol"},{"key":"3602_CR81","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.3389\/fpubh.2022.1062942","volume":"10","author":"Z Ma","year":"2022","unstructured":"Ma Z, Chu X, Yan X, Wang W (2022) Association between Helicobacter pylori infection and non-alcoholic fatty liver disease for Asian and non-Asian population: a systematic review and meta-analysis. Front Public Health 10:4838","journal-title":"Front Public Health"},{"key":"3602_CR82","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1136\/gut.2006.101634","volume":"56","author":"P Malfertheiner","year":"2007","unstructured":"Malfertheiner P et al (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut 56:772\u2013781","journal-title":"Gut"},{"key":"3602_CR83","first-page":"141","volume":"34","author":"H Mao","year":"2014","unstructured":"Mao H, Li R (2014) Changes in serum pepsinogen in patients with liver cirrhosis and portal hypertensive gastropathy. Nan Fang Yi Ke Da Xue Xue Bao J South Med Univ 34:141\u2013143","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao J South Med Univ"},{"key":"3602_CR84","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","volume":"323","author":"B Marshall","year":"1984","unstructured":"Marshall B, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 323:1311\u20131315","journal-title":"Lancet"},{"key":"3602_CR85","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3389\/fendo.2021.639856","volume":"12","author":"GM Martin-Nu\u00f1ez","year":"2021","unstructured":"Martin-Nu\u00f1ez GM, Cornejo-Pareja I, Clemente-Postigo M, Tinahones FJ (2021) Gut microbiota: the missing link between Helicobacter pylori infection and metabolic disorders? Front Endocrinol 12:657","journal-title":"Front Endocrinol"},{"key":"3602_CR86","doi-asserted-by":"publisher","first-page":"354","DOI":"10.4103\/mmj.mmj_171_19","volume":"34","author":"SA Mehesin","year":"2021","unstructured":"Mehesin SA, Badr SA, Elshazli HA, Ghoneim YA, Soliman SS, Albahnasy RE (2021) Epidemiology of Helicobacter pylori infection among children (6\u201312 years) in Menoufia Governorate. Menoufia Med J 34:354","journal-title":"Menoufia Med J"},{"key":"3602_CR87","doi-asserted-by":"crossref","unstructured":"Mekonnen HD, Fisseha H, Getinet T, Tekle F, Galle PR (2018) Helicobacter pylori infection as a risk factor for hepatocellular carcinoma: a case-control study in ethiopia. Int J Hepatol 2018","DOI":"10.1155\/2018\/1941728"},{"key":"3602_CR88","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12734","volume":"25","author":"L Mezmale","year":"2020","unstructured":"Mezmale L, Coelho LG, Bordin D, Leja MJH (2020) Epidemiology of Helicobacter pylori. Helicobacter 25:e12734","journal-title":"Helicobacter"},{"issue":"124\u2013131","key":"3602_CR89","volume":"14","author":"S Mittal","year":"2016","unstructured":"Mittal S et al (2016) Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 14(124\u2013131):e121","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3602_CR90","first-page":"251","volume":"64","author":"I Mladenova","year":"2018","unstructured":"Mladenova I, Durazzo M (2018) Transmission of Helicobacter pylori. Min Gastroenterol Dietol 64:251\u2013254","journal-title":"Min Gastroenterol Dietol"},{"key":"3602_CR91","doi-asserted-by":"crossref","unstructured":"Mohammed HA, Obaid ZH (2022) Pathogenesis of Helicobacter pylori: an overview of bacterial virulence agents and the mechanism of occurrence disease. J Univ Babylon Pure Appli Sci 47\u201353","DOI":"10.29196\/jubpas.v30i1.4063"},{"key":"3602_CR92","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1128\/JCM.38.3.1072-1076.2000","volume":"38","author":"H-O Nilsson","year":"2000","unstructured":"Nilsson H-O, Taneera J, Castedal M, Glatz E, Olsson R, Wadstr\u00f6m T (2000) Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 38:1072\u20131076","journal-title":"J Clin Microbiol"},{"key":"3602_CR93","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/abr.abr_37_18","volume":"8","author":"SAH Nodoushan","year":"2019","unstructured":"Nodoushan SAH, Nabavi A (2019) The interaction of Helicobacter pylori infection and type 2 diabetes mellitus. Adv Biomed Res 8:15","journal-title":"Adv Biomed Res"},{"key":"3602_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-015-0247-9","volume":"15","author":"K Okushin","year":"2015","unstructured":"Okushin K et al (2015) Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan. BMC Gastroenterol 15:1\u201310","journal-title":"BMC Gastroenterol"},{"key":"3602_CR95","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.3748\/wjg.v24.i32.3617","volume":"24","author":"K Okushin","year":"2018","unstructured":"Okushin K et al (2018a) Helicobacter pylori infection and liver diseases: epidemiology and insights into pathogenesis. World J Gastroenterol 24:3617","journal-title":"World J Gastroenterol"},{"key":"3602_CR96","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.3390\/cancers14082039","volume":"14","author":"G Pappas-Gogos","year":"2022","unstructured":"Pappas-Gogos G, Tepelenis K, Fousekis F, Katsanos K, Pitiakoudis M, Vlachos K (2022) The implication of gastric microbiome in the treatment of gastric cancer. Cancers 14:2039","journal-title":"Cancers"},{"key":"3602_CR97","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1365-2893.2009.01263.x","volume":"18","author":"J Parkes","year":"2011","unstructured":"Parkes J et al (2011) Enhanced liver fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C. J Viral Hepat 18:23\u201331","journal-title":"J Viral Hepat"},{"key":"3602_CR98","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.3748\/wjg.v21.i13.3773","volume":"21","author":"S Paydas","year":"2015","unstructured":"Paydas S (2015) Helicobacter pylori eradication in gastric diffuse large B cell lymphoma. World J Gastroenterol 21:3773","journal-title":"World J Gastroenterol"},{"key":"3602_CR99","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/MEG.0000000000000928","volume":"29","author":"J Pogorzelska","year":"2017","unstructured":"Pogorzelska J, \u0141api\u0144ska M, Kalinowska A, \u0141api\u0144ski TW, Flisiak R (2017) Helicobacter pylori infection among patients with liver cirrhosis. Eur J Gastroenterol Hepatol 29:1161","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3602_CR100","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.mehy.2014.03.003","volume":"82","author":"SA Polyzos","year":"2014","unstructured":"Polyzos SA, Kountouras J, Zavos C, Deretzi G (2014) Helicobacter pylori infection, insulin resistance and nonalcoholic fatty liver disease. Med Hypotheses 82:795\u2013795","journal-title":"Med Hypotheses"},{"key":"3602_CR101","doi-asserted-by":"publisher","first-page":"iii","DOI":"10.1016\/j.metabol.2019.05.006","volume":"96","author":"SA Polyzos","year":"2019","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS (2019) Helicobacter pylori infection and nonalcoholic fatty liver disease: are the four meta-analyses favoring an intriguing association pointing to the right direction? Metabolism 96:iii\u2013v","journal-title":"Metabolism"},{"key":"3602_CR102","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1053\/j.gastro.2017.12.043","volume":"154","author":"A Ponzetto","year":"2018","unstructured":"Ponzetto A, Figura N (2018) Risk of Hepatocellular Carcinoma After Cure of Hepatitis C Virus. Gastroenterology 154:1549","journal-title":"Gastroenterology"},{"key":"3602_CR103","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1111\/hdi.12647","volume":"22","author":"L Puchades Renau","year":"2018","unstructured":"Puchades Renau L, Berenguer M (2018) Introduction to hepatitis C virus infection: overview and history of hepatitis C virus therapies. Hemodial Int 22:S8\u2013S21","journal-title":"Hemodial Int"},{"key":"3602_CR104","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/jgh3.12448","volume":"5","author":"MM Rahman","year":"2021","unstructured":"Rahman MM et al (2021) Seroprevalence of Helicobacter pylori and its association with metabolic syndrome in a rural community of Bangladesh. JGH Open 5:64\u201372","journal-title":"JGH Open"},{"key":"3602_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43066-020-00071-7","volume":"11","author":"M Rakha","year":"2021","unstructured":"Rakha M, Saleh O, Abdelgawad MS, El Baiomy A (2021) Helicobacter pylori infection in patients with metabolic syndrome, with or without nonalcoholic fatty liver disease. Egypt Liver J 11:1\u20139","journal-title":"Egypt Liver J"},{"key":"3602_CR106","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009477.pub2","author":"Q Ren","year":"2016","unstructured":"Ren Q, Yan X, Zhou Y, Li WX (2016) Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD009477.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"3602_CR107","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"S Rizvi","year":"2018","unstructured":"Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ (2018) Cholangiocarcinoma\u2014evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 15:95\u2013111","journal-title":"Nat Rev Clin Oncol"},{"key":"3602_CR108","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4103\/2277-9175.133256","volume":"3","author":"H Salehi","year":"2014","unstructured":"Salehi H, Minakari M, Yaghoutkar A, Tabesh E, Salehi M, Mirbagher L (2014) The effect of Helicobacter pylori eradication on liver enzymes in patients referring with unexplained hypertransaminasemia. Ad Biomed Res 3:131","journal-title":"Ad Biomed Res"},{"key":"3602_CR109","first-page":"1004","volume":"63","author":"V Sandhu","year":"2004","unstructured":"Sandhu V, Jawad A (2004) Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 63:1004\u20131005","journal-title":"Ann Rheum Dis"},{"key":"3602_CR110","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11010-007-9462-1","volume":"303","author":"P Sar","year":"2007","unstructured":"Sar P, Rath B, Subudhi U, Chainy GBN, Supakar PC (2007) Alterations in expression of senescence marker protein-30 gene by 3, 3\u2032, 5-triiodo-L-thyronine (T3). Mol Cell Biochem 303:239\u2013242","journal-title":"Mol Cell Biochem"},{"key":"3602_CR111","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.beha.2016.11.002","volume":"30","author":"M Sassone","year":"2017","unstructured":"Sassone M, Ponzoni M, Ferreri AJ (2017) Ocular adnexal marginal zone lymphoma: clinical presentation, pathogenesis, diagnosis, prognosis, and treatment. Best Pract Res Clin Haematol 30:118\u2013130","journal-title":"Best Pract Res Clin Haematol"},{"key":"3602_CR112","unstructured":"\u0160atait\u0117 M, Gelman S (2022) Associations between Helicobacter pylori infection and non-alcoholic fatty liver disease. 2. Karolina Grinkevi\u010di\u016bt\u0117, Chairwoman of the Organising Committee p 79\u201381"},{"key":"3602_CR113","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"E Seki","year":"2007","unstructured":"Seki E et al (2007) TLR4 enhances TGF-\u03b2 signaling and hepatic fibrosis. Nat Med 13:1324\u20131332","journal-title":"Nat Med"},{"key":"3602_CR114","doi-asserted-by":"publisher","first-page":"45","DOI":"10.21608\/ejaps.2017.183773","volume":"55","author":"WM Serag","year":"2017","unstructured":"Serag WM et al (2017) Helicobacter pylori infection; immunohistochemical in hepatic tissue biopsies and serum IgG antibody of hepatitis C virus infected patients. Egypt J Pure Appl Sci 55:45\u201350","journal-title":"Egypt J Pure Appl Sci"},{"key":"3602_CR115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0267230","volume":"17","author":"E Seyoum","year":"2022","unstructured":"Seyoum E, Demissie M, Worku A, Mulu A, Abdissa A, Berhane Y (2022) HIV, hepatitis B virus, and hepatitis C virus co-infection among HIV positives in antiretroviral treatment program in selected hospitals in Addis Ababa: a retrospective cross-sectional study. PLoS ONE 17:e0267230","journal-title":"PLoS ONE"},{"key":"3602_CR116","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s42770-021-00675-0","volume":"53","author":"HC Sharndama","year":"2022","unstructured":"Sharndama HC, Mba IE (2022) Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms. Braz J Microbiol 53:33\u201350","journal-title":"Braz J Microbiol"},{"key":"3602_CR117","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3109\/00365521.2015.1019918","volume":"50","author":"P Sipponen","year":"2015","unstructured":"Sipponen P, Maaroos H-I (2015) Chronic gastritis. Scand J Gastroenterol 50:657\u2013667","journal-title":"Scand J Gastroenterol"},{"key":"3602_CR118","first-page":"759","volume":"100","author":"A Smith","year":"2019","unstructured":"Smith A, Baumgartner K, Bositis C (2019) Cirrhosis: diagnosis and management. Am Fam Physician 100:759\u2013770","journal-title":"Am Fam Physician"},{"key":"3602_CR119","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3748\/wjg.v20.i3.613","volume":"20","author":"DS Smyk","year":"2014","unstructured":"Smyk DS, Koutsoumpas AL, Mytilinaiou MG, Rigopoulou EI, Sakkas LI, Bogdanos DP (2014) Helicobacter pylori and autoimmune disease: cause or bystander. World J Gastroenterol WJG 20:613","journal-title":"World J Gastroenterol WJG"},{"key":"3602_CR120","doi-asserted-by":"publisher","first-page":"e03755-21","DOI":"10.1128\/mbio.03755-21","volume":"13","author":"S Suerbaum","year":"2022","unstructured":"Suerbaum S et al (2022) Identification of antimotilins, novel inhibitors of Helicobacter pylori flagellar motility that inhibit stomach colonization in a mouse model. Mbio 13:e03755-21","journal-title":"Mbio"},{"key":"3602_CR121","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s00535-015-1039-2","volume":"50","author":"Y Sumida","year":"2015","unstructured":"Sumida Y et al (2015) Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease. J Gastroenterol 50:996\u20131004","journal-title":"J Gastroenterol"},{"key":"3602_CR122","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1053\/j.gastro.2010.07.009","volume":"139","author":"MG Swain","year":"2010","unstructured":"Swain MG et al (2010) A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin. Gastroenterology 139:1593\u20131601","journal-title":"Gastroenterology"},{"key":"3602_CR123","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/jhep.2002.30083","volume":"35","author":"Y Tahashi","year":"2002","unstructured":"Tahashi Y et al (2002) Differential regulation of TGF-\u03b2 signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 35:49\u201361","journal-title":"Hepatology"},{"key":"3602_CR124","first-page":"362","volume":"38","author":"Y Takuma","year":"2011","unstructured":"Takuma Y (2011) Helicobacter pylori infection and liver diseases. Gan to Kagaku ryoho. Cancer Chemother 38:362\u2013364","journal-title":"Cancer Chemother"},{"key":"3602_CR125","doi-asserted-by":"crossref","unstructured":"Talebi Bezmin Abadi A (2018) Diagnosis of Helicobacter pylori using invasive and noninvasive approaches. J Pathog 2018","DOI":"10.1155\/2018\/9064952"},{"key":"3602_CR126","first-page":"664","volume":"31","author":"A Tanaka","year":"1999","unstructured":"Tanaka A et al (1999) Are infectious agents involved in primary biliary cirrhosis? A PCR Approach J Hepatol 31:664\u2013671","journal-title":"A PCR Approach J Hepatol"},{"key":"3602_CR127","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1513\/AnnalsATS.201411-513OC","volume":"12","author":"SL Taylor","year":"2015","unstructured":"Taylor SL, Rogers GB, Chen AC-H, Burr LD, McGuckin MA, Serisier DJ (2015) Matrix metalloproteinases vary with airway microbiota composition and lung function in non\u2013cystic fibrosis bronchiectasis. Ann Am Thorac Soc 12:701\u2013707","journal-title":"Ann Am Thorac Soc"},{"key":"3602_CR128","first-page":"780","volume":"13","author":"X Tian","year":"2005","unstructured":"Tian X, Fan X, Fu C, Huang Y, Zhu C (2005) Experimental study on the pathological effect of Helicobacter pylori on liver tissues. Zhonghua Gan Zang Bing Za Zhi= Zhonghua Ganzangbing Zazhi= Chinese J Hepatol 13:780\u2013783","journal-title":"Zhonghua Gan Zang Bing Za Zhi= Zhonghua Ganzangbing Zazhi= Chinese J Hepatol"},{"key":"3602_CR129","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.4254\/wjh.v7.i18.2136","volume":"7","author":"M Waluga","year":"2015","unstructured":"Waluga M, Kukla M, \u017borniak M, Bacik A, Kotulski R (2015) From the stomach to other organs: Helicobacter pylori and the liver. World J Hepatol 7:2136","journal-title":"World J Hepatol"},{"key":"3602_CR130","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12761","volume":"25","author":"B Wang","year":"2020","unstructured":"Wang B, Yu M, Zhang R, Chen S, Xi Y, Duan GJH (2020) A meta-analysis of the association between Helicobacter pylori infection and risk of atherosclerotic cardiovascular disease. Helicobacter 25:e12761","journal-title":"Helicobacter"},{"key":"3602_CR131","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.7150\/ijms.50748","volume":"18","author":"J Wang","year":"2021","unstructured":"Wang J et al (2021) H. pylori is related to NAFLD but only in female: a cross-sectional study. Int J Med Sci 18:2303","journal-title":"Int J Med Sci"},{"key":"3602_CR132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-021-02073-0","volume":"22","author":"W Wang","year":"2022","unstructured":"Wang W et al (2022) Helicobacter pylori infection is not an independent risk factor of non-alcoholic fatty liver disease in China. BMC Gastroenterol 22:1\u201310","journal-title":"BMC Gastroenterol"},{"key":"3602_CR133","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0140-6736(83)92719-8","volume":"321","author":"JR Warren","year":"1983","unstructured":"Warren JR, Marshall B (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 321:1273\u20131275","journal-title":"Lancet"},{"key":"3602_CR134","doi-asserted-by":"publisher","first-page":"e26706","DOI":"10.1097\/MD.0000000000026706","volume":"100","author":"L Wei","year":"2021","unstructured":"Wei L, Ding H-G (2021) Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease: What should we expect from a meta-analysis? Medicine 100:e26706","journal-title":"Medicine"},{"key":"3602_CR135","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/ajg.2015.235","volume":"110","author":"JL Wei","year":"2015","unstructured":"Wei JL et al (2015) Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using proton-magnetic resonance spectroscopy. Off J Am Coll Gastroenterol ACG 110:1306\u20131314","journal-title":"Off J Am Coll Gastroenterol ACG"},{"key":"3602_CR136","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4806.22.07928-9","author":"S Wernly","year":"2022","unstructured":"Wernly S et al (2022) Non-alcoholic fatty liver disease is not independently associated with Helicobacter pylori in a Central European screening cohort. Minerva Med. https:\/\/doi.org\/10.23736\/S0026-4806.22.07928-9","journal-title":"Minerva Med"},{"key":"3602_CR137","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/microorganisms10020322","volume":"10","author":"B White","year":"2022","unstructured":"White B, Winte M, DeSipio J, Phadtare SJM (2022) Clinical factors implicated in antibiotic resistance in Helicobacter pylori patients. Microorganisms 10:322","journal-title":"Microorganisms"},{"key":"3602_CR138","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9797841","author":"M-Y Xu","year":"2020","unstructured":"Xu M-Y et al (2020) Nonalcoholic fatty liver disease is associated with Helicobacter pylori infection in north urban Chinese: a retrospective study. Gastroenterol Res Pract. https:\/\/doi.org\/10.1155\/2020\/9797841","journal-title":"Gastroenterol Res Pract"},{"key":"3602_CR139","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/jmv.24912","volume":"90","author":"T Yang","year":"2018","unstructured":"Yang T et al (2018) High prevalence of syphilis, HBV, and HCV co-infection, and low rate of effective vaccination against hepatitis B in HIV-infected patients in West China hospital. J Med Virol 90:101\u2013108","journal-title":"J Med Virol"},{"key":"3602_CR140","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jhep.2020.01.027","volume":"73","author":"M-L Yeh","year":"2020","unstructured":"Yeh M-L et al (2020) Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV\/HCV co-infection. J Hepatol 73:62\u201371","journal-title":"J Hepatol"},{"key":"3602_CR141","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1177\/09612033221094708","volume":"31","author":"O Yetginoglu","year":"2022","unstructured":"Yetginoglu O et al (2022) Fibroscan detection of fatty liver and liver fibrosis in patients with systemic lupus erythematosus. Lupus 31:723\u2013729","journal-title":"Lupus"},{"key":"3602_CR142","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1099\/jmm.0.039040-0","volume":"61","author":"H Yonezawa","year":"2012","unstructured":"Yonezawa H et al (2012) Destructive effects of butyrate on the cell envelope of Helicobacter pylori. J Med Microbiol 61:582\u2013589","journal-title":"J Med Microbiol"},{"key":"3602_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-23746-0","volume":"12","author":"Y-Y Yu","year":"2022","unstructured":"Yu Y-Y, Tong Y-l, Wu L-Y, Yu X-Y (2022) Helicobacter pylori infection eradication for nonalcoholic fatty liver disease: a randomized controlled trial. Sci Rep 12:1\u201310","journal-title":"Sci Rep"},{"key":"3602_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.857570","author":"ME Zahmatkesh","year":"2022","unstructured":"Zahmatkesh ME et al (2022) Effects of exosomes derived from Helicobacter pylori outer membrane vesicle-infected hepatocytes on hepatic stellate cell activation and liver fibrosis induction. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2022.857570","journal-title":"Front Cell Infect Microbiol"},{"key":"3602_CR145","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/apt.14561","volume":"47","author":"M Zamani","year":"2018","unstructured":"Zamani M et al (2018) Systematic review with meta-analysis: the worldwide prevalence of helicobacter pylori infection. Aliment Pharmacol Ther 47:868\u2013876","journal-title":"Aliment Pharmacol Ther"},{"key":"3602_CR146","doi-asserted-by":"crossref","unstructured":"Zeng Y, Jing X, Wu C, Xie Y, Chen L et al (2022) Is Helicobacter pylori infection the risk factor of metabolic associated fatty liver disease: a cross-sectional study.","DOI":"10.21203\/rs.3.rs-2005721\/v1"},{"key":"3602_CR147","first-page":"123","volume":"39","author":"S Zordok","year":"2022","unstructured":"Zordok S, Sadek Y, Abdel Aziz B, Behiry E (2022) Helicobacter pylori infection in patients with non alcholic fatty liver disease. Benha Med J 39:123\u2013135","journal-title":"Benha Med J"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-023-03602-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-023-03602-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-023-03602-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T09:04:49Z","timestamp":1691744689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-023-03602-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":147,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["3602"],"URL":"https:\/\/doi.org\/10.1007\/s00203-023-03602-z","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,11]]},"assertion":[{"value":"27 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"281"}}